Gujarat Themis Biosyn Limited (GUJTHEM) — Voting Results | 23 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Shareholders approved amendment to Articles of Association removing mandatory share valuation clause.
🔄 What Changed
Removed requirement for registered valuer approval in share issuance under Article 13(1)(c).
💡 Investor Takeaway
This change gives the company more flexibility to issue shares without mandatory third-party valuation, potentially speeding up capital raises.

Gujarat Themis Biosyn Limited amended its Articles of Association by deleting a clause requiring share price valuation by a registered valuer for certain share issuances, simplifying the process for issuing shares for cash or non-cash consideration to any persons. The change was approved by shareholders via special resolution on 22 August 2026 and filed with exchanges on 23 August 2026.

📄 View Original Announcement (PDF)

About Gujarat Themis Biosyn Limited (GUJTHEM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,604.87 Cr

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

📊 More GUJTHEM filings

See all GUJTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day